Lymphoma News

FDA issued a safety alert Thursday regarding reports of squamous cell carcinoma and various lymphomas in the scar tissue surrounding breast implants.

Before the opening of City of Hope’s new comprehensive cancer center, many residents of Orange County, California, faced a long commute for advanced cancer care.

A recent comparative analysis shed light on the differences between subcutaneous panniculitis-like T-cell lymphoma and the similar adipotropic lymphoproliferative disorder, according to a study.

Oncologists who treat non-Hodgkin lymphoma have increasingly become reliant on targeted treatment, with several new agents receiving FDA approval within the past 5 years.

Several hematologists will be honored during this year’s ASH Annual Meeting, scheduled for Dec. 10-13 in New Orleans.

Certain patient demographics, including race and ethnicity and underlying primary malignant neoplasm, appeared associated with delays in cancer treatment among patients with COVID-19.

Rates for CV admissions among patients with cancer has increased, according to a study published in the European Heart Journal Quality of Care & Clinical Outcomes.Primary CV admissions are highest among patients with hematological cancer with the most common cause of admission being heart failure, according to the study.

Luis E. Malpica Castillo, MD, of The University of Texas MD Anderson Cancer Center received the ASH-Harold Amos Medical Faculty Development Program Award.

The advent of novel therapies has propelled, and continues to propel, tremendous progress and innovation in diffuse large B-cell lymphoma.

A third dose of the mRNA-1273 vaccine for COVID-19 significantly improved SARS-CoV-2 antibody concentrations among patients with hematologic malignancies who previously received two doses, results of a prospective study showed.